DB
GNCA

Dmitry Balyasny’s Genocea Biosciences, Inc. GNCA Stock Holding History

Dmitry Balyasny’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,261
Closed -$145K – 2343
2018
Q1 		$145K Sell
17,261
-10,075
-37% -$83.7K ﹤0.01% 1799
2017
Q4 		$254K Buy
27,336
+13,788
+102% +$139K ﹤0.01% 1809
2017
Q3 		$158K Buy
+13,548
New +$514K ﹤0.01% 1735
2016
Q3 		– Sell
-1,349
Closed -$44K – 1397
2016
Q2 		$44K Buy
+1,349
New +$49.4K ﹤0.01% 1120
2016
Q1 		– Sell
-1,388
Closed -$58K – 1643
2015
Q4 		$58K Buy
+1,388
New +$66.1K ﹤0.01% 1185

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's GNCA Position: Q2 2018 in Review

Dmitry Balyasny sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 17,261 shares — an estimated $145K sold.

Dmitry Balyasny first reported a position in GNCA in Q4 2015 and held it in 5 quarters. The position peaked at $254K in Q4 2017. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • Dmitry Balyasny reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Dmitry Balyasny sold 17,261 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $145K.
  • Dmitry Balyasny first reported a position in Genocea Biosciences, Inc. in Q4 2015 and held it in 5 quarters.
  • Dmitry Balyasny's Genocea Biosciences, Inc. position peaked at $254K in Q4 2017.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.